Marieke van Son

186 CHAPTER 10 14. Marra G, Gontero P, Walz JC, Sivaraman A, Tourinho-Barbosa R, Cathelineau X, et al. Complications, oncological and functional outcomes of salvage treat- ment options following focal therapy for localized prostate cancer: a system- atic review and a comprehensive nar- rative review. World journal of urology. 2019;37(8):1517-34. 15. Marra G, Valerio M, Emberton M, Heiden- reich A, Crook JM, Bossi A, et al. Salvage Local Treatments After Focal Therapy for Prostate Cancer. Eur Urol Oncol. 2019;2(5):526-38. 16. Wenske S, Quarrier S, Katz AE. Salvage cryosurgery of the prostate for failure after primary radiotherapy or cryosur- gery: long-term clinical, functional, and oncologic outcomes in a large cohort at a tertiary referral centre. Eur Urol. 2013;64(1):1-7. 17. Guillaumier S, Peters M, Arya M, Afzal N, Charman S, Dudderidge T, et al. A Mul- ticentre Study of 5-year Outcomes Fol- lowing Focal Therapy in Treating Clini- cally Significant Nonmetastatic Prostate Cancer. Eur Urol. 2018;74(4):422-9. 18. Marconi L, Stonier T, Tourinho-Barbosa R, Moore C, Ahmed HU, Cathelineau X, et al. Robot-assisted Radical Prostatec- tomy After Focal Therapy: Oncological, Functional Outcomes and Predictors of Recurrence. Eur Urol. 2019;76(1):27-30. 19. Karavitakis M, Winkler M, Abel P, Livni N, Beckley I, Ahmed HU. Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: implications for focal ther- apy. Prostate cancer and prostatic dis- eases. 2011;14(1):46-52. 20. van der Poel HG, van den Bergh RCN, Briers E, Cornford P, Govorov A, Henry AM, et al. Focal Therapy in Primary Lo- calised Prostate Cancer: The European Association of Urology Position in 2018. Eur Urol. 2018;74(1):84-91. 21. Golbari NM, Katz AE. Salvage Thera- py Options for Local Prostate Cancer Recurrence After Primary Radiothera- py: a Literature Review. Curr Urol Rep. 2017;18(8):63. 22. Alongi F, De Bari B, Campostrini F, Ar- cangeli S, Matei DV, Lopci E, et al. Sal- vage therapy of intraprostatic failure after radical external-beam radiother- apy for prostate cancer: a review. Crit- ical reviews in oncology/hematology. 2013;88(3):550-63. 23. Valle LF, Lehrer EJ, Markovic D, Elashoff D, Levin-Epstein R, Karnes RJ, et al. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radio- therapy for Prostate Cancer (MASTER). Eur Urol. 2020. 24. Haj-Hamed M, Karivedu V, Sidana A. Salvage treatment for radio-recurrent prostate cancer: a review of literature with focus on recent advancements in image-guided focal salvage therapies. International urology and nephrology. 2019;51(7):1101-6. 25. Khoo CC, Miah S, Connor MJ, Tam J, Winkler M, Ahmed HU, et al. A system- atic review of salvage focal therapies for localised non-metastatic radiorecurrent prostate cancer. Translational andrology and urology. 2020;9(3):1535-45. 26. Nair SM, Peters M, Kurver P, Lavi A, Ver- hoeff JJC, van der Voort van Zyp JRN, et al. Long-term outcomes of two ablation techniques for treatment of radio-recur- rent prostate cancer. Prostate cancer and prostatic diseases. 2020. 27. Evans JD, Jethwa KR, Ost P, Williams S, Kwon ED, Lowe VJ, et al. Prostate cancer-specific PET radiotracers: A review on the clinical utility in recurrent disease. Practical radiation oncology. 2018;8(1):28-39.